REMI Financials 07/16/2014 16:10:27 Remedent, Inc

REMI Financials 07/16/2014 16:10:27
Remedent, Inc.
Period Ending Mar 31, 2013 Mar 31, 2012 Mar 31, 2011 Mar 31, 2010
Total Revenue 2,937 9,687 12,582 8,248
Cost of Revenue 1,433 2,228 3,948 4,323
Gross Profit 1,504 7,459 8,634 3,925
Operating Expenses
Research and Development 60 310 429 271
Sales, General and Admin. 2,944 7,103 7,194 5,877
Non-Recurring Items - - - -
Other 314 549 780 726
Operating Income (1,814) (502) 231 (2,949)
Income From Continuing Operations
Add'l Income/Expense Items 818 2,330 (591) 2
Earnings Before Interest and Tax (796) 2,001 (359) (2,947)
Interest Expense 186 387 260 171
Earnings Before Tax (982) 1,614 (620) (3,118)
Income Tax - 315 220 14
Minority Interest - 808 707 783
Equity Earnings Unconsolidated Subsidiary 200 173 - -
Net Income Cont. Operations (782) 664 (1,547) (3,915)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (782) 664 (1,547) (3,915)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (982) 490 (1,547) (2,350)